BIOMERICA INC
Financial highlights
| Metric | FY May 31, 2025 | FY May 31, 2024 | FY May 31, 2023 | FY May 31, 2022 | FY May 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $5.3M | $5.4M | $5.3M | $18.9M | $7.2M |
| Gross profit | $498,000 | $611,000 | $446,000 | $3.0M | $366,285 |
| Operating income | -$5.1M | -$6.4M | -$7.2M | -$4.5M | -$7.5M |
| Operating expenses | $5.6M | $7.0M | $7.7M | $7.5M | $7.9M |
| Cost of revenue | $4.8M | $4.8M | $4.9M | $15.9M | $6.8M |
| Cash from operations | -$3.8M | -$5.4M | -$5.5M | -$479,000 | -$5.3M |
| Capital expenditure | — | $51,000 | $64,000 | $57,000 | $135,856 |
| Free cash flow | — | -$5.4M | -$5.5M | -$536,000 | -$5.4M |
| Impairments | — | — | $0 | $210,000 | $0 |
| Total assets | $5.9M | $9.3M | $14.5M | $11.4M | $11.8M |
| Total liabilities | $1.8M | $2.7M | $2.7M | $3.0M | $2.6M |
Shares outstanding 3.1M · Free float 63.9%
Annual filing data through FY ended May 31, 2025; float as of July 8, 2026.